| IDE | insulin-degrading enzyme; investigational device exemption |
|---|---|
| IDI | immunologically detectable insulin; induction-delivery interval; inter-dentale inferius |
| IFP | inflammatory fibroid polyp; insulin, compound F [hydrocortisone], prolactin; intermediate filament p... |
| IG | immature granule; immunoglobulin; insulin and glucose; intragastric; irritable gut |
| IGF | insulin-like growth factor |
| insulin r.’s |
specific membrane receptors for insulin found on target cells. When insulin binds to a receptor, either the receptor protein kinase is activated, leading to the activation of other protein kinases within the cell, or the occupied receptors move to coated pits and are endocytosed; in the latter case, in addition to the effects mediated by kinases, a few effects may depend on degradation products.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|---|
| insulin s. |
a hypoglycemic reaction to overdosage of insulin, a skipped meal, or strenuous exercise in an insulin-dependent diabetic; early symptoms are tremor, irritability, dizziness, cool moist skin, hunger, and tachycardia; if untreated it can progress to coma (see diabetic coma) and convulsions. Called also hypoglycemic s.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| insulin-dependent d. mellitus |
type 1 d. mellitus.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| insulin-induced h. |
factitial h.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| insulinlike growth f.’s |
serum peptides with insulin-like actions, formerly called somatomedins (q.v.). IGF-I (formerly somatomedin C) is an important growth hormone–dependent mediator of cell growth and replication. IGF-II (formerly somatomedin A) appears to be essential for normal embryonic development and may play special roles in the central nervous system. Both are similar in sequence and structure to proinsulin.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|